Biotech sector crafts response to R&D tax incentive review


11 October 2016 - AusBiotech members are invited to gather at briefings in Sydney, Brisbane and Melbourne to contribute to the crafting of the industry’s response to the ‘Ferris, Finkel, Fraser’ Review of the Research & Development (R&D) Tax Incentive.

The Report’s recent launch has already drawn a strong response from industry with a package of recommendations that include placing a $2 million cap on the refundable component of the programme that would disadvantage a significant portion of SMEs in the sector.

The Report’s launch marked the commencement of a consultation period, which is now open until 28 October with feedback invited on the six recommendations.

Read AusBiotech update

Michael Wonder

Posted by:

Michael Wonder